These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 17989653)

  • 41. Personal responsibility and the Food and Drug Law.
    Janssen WF
    FDA Consum; 1975 Nov; 9(9):10-3. PubMed ID: 10308122
    [No Abstract]   [Full Text] [Related]  

  • 42. New York's generic drug substitution law.
    Kamen A
    N Y State Dent J; 1980 Nov; 46(9):599-604. PubMed ID: 6935574
    [No Abstract]   [Full Text] [Related]  

  • 43. FDA joins market.
    Gershon D
    Nature; 1993 Jul; 364(6433):93. PubMed ID: 8321293
    [No Abstract]   [Full Text] [Related]  

  • 44. New law gives FDA more influence to monitor drug safety.
    Wadman M
    Nat Med; 2007 Nov; 13(11):1269. PubMed ID: 17987008
    [No Abstract]   [Full Text] [Related]  

  • 45. FDA backs legislation to restrict antimicrobial use.
    Cima G
    J Am Vet Med Assoc; 2009 Sep; 235(5):493-5. PubMed ID: 19731457
    [No Abstract]   [Full Text] [Related]  

  • 46. Reaction of FDA to a fundamental change in the nature of regulations.
    Kennedy D
    J Parenter Drug Assoc; 1979; 33(1):17-20. PubMed ID: 253023
    [No Abstract]   [Full Text] [Related]  

  • 47. A strike against preemption.
    Nat Biotechnol; 2009 May; 27(5):397. PubMed ID: 19430422
    [TBL] [Abstract][Full Text] [Related]  

  • 48. FDA user fee plan gets some support from drug makers.
    Weissenstein E
    Mod Healthc; 1992 Aug; 22(33):20. PubMed ID: 10119804
    [No Abstract]   [Full Text] [Related]  

  • 49. The FDA Safety and Innovation Act.
    Steinbrook R; Sharfstein JM
    JAMA; 2012 Oct; 308(14):1437-8. PubMed ID: 23047356
    [No Abstract]   [Full Text] [Related]  

  • 50. Pharmaceutical research--and the FDA.
    Am Fam Physician; 1978 Jul; 18(1):67-8. PubMed ID: 665475
    [No Abstract]   [Full Text] [Related]  

  • 51. The drug approval process and the FDA.
    Schmidt AM
    Conn Med; 1975 Apr; 39(4):237-40. PubMed ID: 1149447
    [No Abstract]   [Full Text] [Related]  

  • 52. The new law: public law 109-462 for dietary supplements.
    Jiang T
    Eur J Clin Nutr; 2009 Feb; 63(2):300. PubMed ID: 17851457
    [No Abstract]   [Full Text] [Related]  

  • 53. Dirty dancing--the FDA stumbles with the Chevron two-step: a response to professor Noah.
    Lawson G
    Cornell Law Rev; 2008 Jul; 93(5):927-38. PubMed ID: 18618964
    [No Abstract]   [Full Text] [Related]  

  • 54. FDA milestones.
    FDA Consum; 2006; 40(1):36-8. PubMed ID: 16528826
    [TBL] [Abstract][Full Text] [Related]  

  • 55. US drug industry and FDA prepare for closer ties.
    Ashraf H
    Lancet; 2002 Jun; 359(9321):1923. PubMed ID: 12057560
    [No Abstract]   [Full Text] [Related]  

  • 56. Has the Food and Drug Administration abused its authority in attempting to regulate veterinary compounding?
    Siegner AW
    J Am Vet Med Assoc; 1994 Jul; 205(2):243-7. PubMed ID: 7928589
    [No Abstract]   [Full Text] [Related]  

  • 57. Communicating with the FDA: the "third rail" of a new model for drug development.
    Stanski DR; Orloff JJ
    J Clin Pharmacol; 2008 Feb; 48(2):144-5. PubMed ID: 18199890
    [No Abstract]   [Full Text] [Related]  

  • 58. US aims to tighten rules on direct-to-consumer drug ads.
    Vastag B
    Nat Biotechnol; 2007 Mar; 25(3):267. PubMed ID: 17344868
    [No Abstract]   [Full Text] [Related]  

  • 59. The FDA takes action against unapproved drugs.
    Meadows M
    FDA Consum; 2007; 41(1):34-5. PubMed ID: 17342837
    [TBL] [Abstract][Full Text] [Related]  

  • 60. FDA takes action against firms in scandal over generic products.
    Pollner F
    Med World News; 1989 Sep; 30(17):14-5. PubMed ID: 10294736
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.